T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Humana
HUM
|
+$2.39B |
| 2 |
UnitedHealth
UNH
|
+$1.47B |
| 3 |
GE Aerospace
GE
|
+$1.33B |
| 4 |
Amazon
AMZN
|
+$1.18B |
| 5 |
AbbVie
ABBV
|
+$1.13B |
Top Sells
| 1 |
Boeing
BA
|
+$1.56B |
| 2 |
Nike
NKE
|
+$1.42B |
| 3 |
Becton Dickinson
BDX
|
+$1.33B |
| 4 |
Alibaba
BABA
|
+$1.23B |
| 5 |
JPMorgan Chase
JPM
|
+$1.22B |
Sector Composition
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCSB
1026
DELISTED
PCSB Financial Corporation
PCSB
| $22.6M | ﹤0.01% |
1,616,651
+66,802
| +4% | +$935K |
|
1027
EPAM Systems
EPAM
$8.76B
| $22.5M | ﹤0.01% |
121,339
-117,060
| -49% | -$21.7M |
|
1028
Arista Networks
ANET
$183B
| $22.5M | ﹤0.01% |
1,776,544
+145,488
| +9% | +$1.84M |
|
1029
A.O. Smith
AOS
$10.3B
| $22.5M | ﹤0.01% |
594,811
+3,781
| +0.6% | +$143K |
|
1030
Alector
ALEC
$289M
| $22.4M | ﹤0.01% |
+929,364
| New | +$22.4M |
|
1031
Merit Medical Systems
MMSI
$5.27B
| $22.3M | ﹤0.01% |
714,372
+677,012
| +1,812% | +$21.2M |
|
1032
CAE Inc
CAE
$8.57B
| $22.3M | ﹤0.01% |
1,785,751
-17,781
| -1% | -$222K |
|
1033
First Bancorp
FBNC
$2.28B
| $22.2M | ﹤0.01% |
963,598
-73,340
| -7% | -$1.69M |
|
|
BEAT
1034
DELISTED
BioTelemetry, Inc.
BEAT
| $22.2M | ﹤0.01% |
576,428
-2,466
| -0.4% | -$95K |
|
1035
Henry Schein
HSIC
$8.41B
| $22.2M | ﹤0.01% |
438,934
+17,488
| +4% | +$883K |
|
1036
Restaurant Brands International
QSR
$20.7B
| $22M | ﹤0.01% |
549,897
-13,382,082
| -96% | -$536M |
|
1037
Columbia Financial
CLBK
$1.6B
| $22M | ﹤0.01% |
1,526,922
+25,356
| +2% | +$365K |
|
1038
Hawkins
HWKN
$3.62B
| $21.9M | ﹤0.01% |
1,229,144
+17,786
| +1% | +$317K |
|
1039
NCR Voyix
VYX
$1.77B
| $21.8M | ﹤0.01% |
2,008,662
+32,323
| +2% | +$351K |
|
1040
W.W. Grainger
GWW
$48.4B
| $21.8M | ﹤0.01% |
87,578
+6,862
| +9% | +$1.71M |
|
1041
Silgan Holdings
SLGN
$4.75B
| $21.8M | ﹤0.01% |
749,815
+724,060
| +2,811% | +$21M |
|
1042
Quest Diagnostics
DGX
$20.6B
| $21.8M | ﹤0.01% |
270,867
+21,018
| +8% | +$1.69M |
|
|
AAT
1043
American Assets Trust
AAT
$1.27B
| $21.6M | ﹤0.01% |
863,599
+18,031
| +2% | +$451K |
|
|
SBT
1044
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $21.6M | ﹤0.01% |
5,020,308
+50,000
| +1% | +$215K |
|
1045
FMC
FMC
$4.75B
| $21.5M | ﹤0.01% |
263,393
+19,217
| +8% | +$1.57M |
|
1046
10x Genomics
TXG
$1.58B
| $21.5M | ﹤0.01% |
344,894
+160,810
| +87% | +$10M |
|
1047
Novo Nordisk
NVO
$242B
| $21.5M | ﹤0.01% |
+713,596
| New | +$21.5M |
|
|
EPZM
1048
DELISTED
Epizyme, Inc
EPZM
| $21.4M | ﹤0.01% |
1,382,150
-20,943
| -1% | -$325K |
|
1049
KeyCorp
KEY
$21B
| $21.4M | ﹤0.01% |
2,063,747
-160,338
| -7% | -$1.66M |
|
1050
UDR
UDR
$12.8B
| $21.3M | ﹤0.01% |
583,502
+45,987
| +9% | +$1.68M |
|